Department of Internal Medicine
Hematology, Oncology and Blood & Marrow Transplantation Faculty
Thomas L. Carlisle, M.D., Ph.D.
Dr. Carlisle's research interests include clinical trials in the treatment of primary brain and spinal cord tumors. Clinical interests are in the treatment of primary brain and spinal cord tumors. I practice in a multidisciplinary Brain Tumor Treatment Clinic in the Holden Comprehensive Cancer Center. I also practice in a general oncology and hematology clinic at the Veterans Affairs Medical Center.
Honors, Awards, and Organizations
- Alpha Omega Alpha
- American Association for the Advancement of Science
- American Chemical Society
- American College of Physicians Sigma Xi
- Lichtman, S.M., Nredzwiecki, D., Barcos, M., Carlisle, T.L., Cooper, M.R., Johnson, J.L., Peterson, B.A.: Phase II Study of Infusional Chemotherapy with Doxorubicin, Vincristine and Etoposide Plus Cyclophosphamide and Prednisone (I-CHOPE) in Resistant Diffuse Aggressive Non-Hodgkins Lymphoma: CALGB 9255. Cancer and Leukemia Group B. Annals of Oncology 11:1141-6, 2000.
- Joyce, D.E., Piett, W.W, Stone, M.S., Carlisle, T.L., Lentz, S.R.: Severe Acquired Protein S Deficiency in a Patient with ANCA-associated Vasculitis. Thrombosis and Hemostasis, 84(5):929-30, 2000.
- Carlisle, T.L., Roncero, C., El Khadir-Mounier, C., Thurmond, D.C., and Goodridge, A.G.: The Malic Enzyme Gene in Chick-Embryo Hepatocytes in Culture: Clofibrate Regulates Responsiveness to Triiodothyronine. J. Lipid Research, 37:2088-2097, 1996.